Form 8-K - Current report:
SEC Accession No. 0001213900-23-013059
Filing Date
2023-02-21
Accepted
2023-02-21 07:01:14
Documents
57
Period of Report
2023-02-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea173990-8k_actinium.htm   iXBRL 8-K 28864
2 PRESS RELEASE, DATED FEBRUARY 18, 2023 ea173990ex99-1_actinium.htm EX-99.1 41408
3 INVESTOR PRESENTATION, DATED FEBRUARY 18, 2023 ea173990ex99-2_actinium.htm EX-99.2 66831
4 GRAPHIC ex99-1_001.jpg GRAPHIC 23411
5 GRAPHIC ex99-2_001.jpg GRAPHIC 77776
6 GRAPHIC ex99-2_002.jpg GRAPHIC 238930
7 GRAPHIC ex99-2_003.jpg GRAPHIC 101707
8 GRAPHIC ex99-2_004.jpg GRAPHIC 137132
9 GRAPHIC ex99-2_005.jpg GRAPHIC 153125
10 GRAPHIC ex99-2_006.jpg GRAPHIC 134925
11 GRAPHIC ex99-2_007.jpg GRAPHIC 119554
12 GRAPHIC ex99-2_008.jpg GRAPHIC 116825
13 GRAPHIC ex99-2_009.jpg GRAPHIC 133568
14 GRAPHIC ex99-2_010.jpg GRAPHIC 127820
15 GRAPHIC ex99-2_011.jpg GRAPHIC 159756
16 GRAPHIC ex99-2_012.jpg GRAPHIC 105579
17 GRAPHIC ex99-2_013.jpg GRAPHIC 147245
18 GRAPHIC ex99-2_014.jpg GRAPHIC 153199
19 GRAPHIC ex99-2_015.jpg GRAPHIC 122906
20 GRAPHIC ex99-2_016.jpg GRAPHIC 135195
21 GRAPHIC ex99-2_017.jpg GRAPHIC 106269
22 GRAPHIC ex99-2_018.jpg GRAPHIC 115268
23 GRAPHIC ex99-2_019.jpg GRAPHIC 133284
24 GRAPHIC ex99-2_020.jpg GRAPHIC 120288
25 GRAPHIC ex99-2_021.jpg GRAPHIC 97273
26 GRAPHIC ex99-2_022.jpg GRAPHIC 106355
27 GRAPHIC ex99-2_023.jpg GRAPHIC 141996
28 GRAPHIC ex99-2_024.jpg GRAPHIC 93859
29 GRAPHIC ex99-2_025.jpg GRAPHIC 126328
30 GRAPHIC ex99-2_026.jpg GRAPHIC 105589
31 GRAPHIC ex99-2_027.jpg GRAPHIC 133978
32 GRAPHIC ex99-2_028.jpg GRAPHIC 111137
33 GRAPHIC ex99-2_029.jpg GRAPHIC 82971
34 GRAPHIC ex99-2_030.jpg GRAPHIC 146124
35 GRAPHIC ex99-2_031.jpg GRAPHIC 136305
36 GRAPHIC ex99-2_032.jpg GRAPHIC 128826
37 GRAPHIC ex99-2_033.jpg GRAPHIC 133072
38 GRAPHIC ex99-2_034.jpg GRAPHIC 139854
39 GRAPHIC ex99-2_035.jpg GRAPHIC 110730
40 GRAPHIC ex99-2_036.jpg GRAPHIC 57168
41 GRAPHIC ex99-2_037.jpg GRAPHIC 101577
42 GRAPHIC ex99-2_038.jpg GRAPHIC 179791
43 GRAPHIC ex99-2_039.jpg GRAPHIC 166006
44 GRAPHIC ex99-2_040.jpg GRAPHIC 154912
45 GRAPHIC ex99-2_041.jpg GRAPHIC 52268
46 GRAPHIC ex99-2_042.jpg GRAPHIC 54042
  Complete submission text file 0001213900-23-013059.txt   7541404

Data Files

Seq Description Document Type Size
47 XBRL LABEL FILE atnm-20230218_lab.xml EX-101.LAB 34240
48 XBRL PRESENTATION FILE atnm-20230218_pre.xml EX-101.PRE 22371
49 XBRL SCHEMA FILE atnm-20230218.xsd EX-101.SCH 3245
51 EXTRACTED XBRL INSTANCE DOCUMENT ea173990-8k_actinium_htm.xml XML 3612
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 23645216
SIC: 2834 Pharmaceutical Preparations